Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DML2CPW)

Drug Name

VAY736 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Pemphigus vulgaris	EB40	Phase 2	[1]
Rheumatoid arthritis	FA20	Phase 2	[2]
Sjogren syndrome	4A43.20	Phase 2	[3]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
B-cell-activating factor receptor (TNFRSF13C)	TT7NJSE	TR13C_HUMAN	Not Available	[4]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	ClinicalTrials.gov (NCT02137889) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients. U.S. National Institutes of Health.
4	National Cancer Institute Drug Dictionary (drug id 762784).